Research

The following individuals have expressed opinions on iCo Therapeutics and may be contacted directly for copies of their reports. Please view our Cautionary Notes regarding this list.

Publication Name Contact
Initiating Coverage

Douglas Loe, Ph.D. MBA, Byron Capital Markets Ltd.

DLoe@byroncapitalmarkets.com

(647) 426-0472

Update Maria Luckevich, M.Sc., MBA,  Loewen, Ondaatje, McCutcheon Limited

mluckevich@lomltd.com

(416) 964-4430

The Next Wave (Dundee Biotech) David Martin, PhD, MBA, Dundee Securities Dundee has since been acquired by Scotiabank.

 

Copyright 2010 ICO Therapeutics | Disclaimer